HEATHER SEDGWICK: Open Payments
NPI 1598251589 · SUTTONS BAY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$783 in 33 payments from 11 companies in 2025. Trend: 2023 $1,300 · 2024 $931 · 2025 $783
Food & beverage: $608Consulting: $175
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $216 |
| Amgen Inc. | 3 | $196 |
| AstraZeneca Pharmaceuticals LP | 6 | $113 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| GlaxoSmithKline, LLC. | 2 | $39 |
| PFIZER INC. | 2 | $34 |
| Exact Sciences Corporation | 1 | $27 |
| Novo Nordisk Inc | 1 | $19 |
| Lilly USA, LLC | 1 | $18 |
Products named: PROLIA, UBRELVY, REXULTI, QULIPTA, VRAYLAR, CAPLYTA, FARXIGA, NEXIUM.
Industry payments across MI — which companies pay providers there.
